Traditional 2D imaging provides surgeons some level of confidence during surgery. Whether it be confidence in their lateral and medial margins relative to their specimens or slight assurance that their area of interest is central to their specimens; however, uncertainty appears when surgeons want to evaluate their anterior and posterior margins. 2D Imaging only provides surgeons with a projection of their specimens resulting in lost information about the extent of calcifications near the anterior & posterior edge.

‍

In this on-demand webinar Dr. Greenwalt will share his insights on why 3D tomosynthesis in the operating is the new gold standard of care in breast cancer surgery. Dr. Greenwalt will provide real cases where he utilized 3D tomosynthesis and discuss the capability that this technology provided him in real-time.

‍

‍

‍

Speaker: Ian Greenwalt, MD, MedStar Georgetown University Hospital

Dr. Ian Greenwalt is a certified breast surgeon practicing in the MedStar Breast Health Program at MedStar Georgetown University Hospital. Dr. Greenwalt specializes in management of both malignant and benign breast disease through the combination of minimally invasive surgical techniques and advanced oncoplastic skills.

‍

‍

‍

‍

Moderator: John Leach, Vice President of Marketing, KUBTEC

John Leach is the Vice President of Marketing at KUBTEC, with responsibility for marketing programs, brand management, and product development. John has worked within the medical device, diagnostics, and biotechnology industries throughout his career helping organizations grow into new markets and build a strong pipeline of leads.